Mitochondrial myopathies here imply the disorders of the respiratory chain that exclusively or predominantly affect the skeletal muscle (DiMauro and Gurgel-Gianneti 2006). They frequently present with multisystem dysfunction and have a broad variety of phenotypes and genetic etiologies. They can be classified genetically into two major groups: those due to mutations in mitochondrial DNA (mtDNA) and those due to mutations in nuclear DNA (nDNA). The prevalence of mitochondrial disorders as a whole is approximately 1 in 10,000 (Schaefer et al. 2008), although the carrier frequency of mtDNA mutations is about 1 in 200 (Elliott et al. 2008).
KeywordsFatigue Lactate Migraine Cortisol Neuropathy
- Chinnery, P. F. (2014). Mitochondrial disorders overview-GeneReviews®-NCBI Bookshelf. Available at www.ncbi.nlm.mih.gov/books/NBK1224.
- Hirano, M., Kaufmann, P., De Vivo, D. C., et al. (2006). Mitochondrial neurology. I: Encephalopathies. In S. DiMauro, M. Hirano, & E. A. Schon (Eds.), Mitochondrial medicine (pp. 27–44). London: Informa Healthcare.Google Scholar
- Taylor, R. W., Schaefer, A. M., Barron, M. J., et al. (2004). The diagnosis of mitochondrial muscle disease. Neuromuscular Disorders, 14, 237–245.Google Scholar